REVIUM Rx. SEC filings RVRC

REVIUM Rx. has 13 filings in SEC EDGAR's recent list, going back to Feb 14, 2025. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 22, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Officer or director change
 Jun 22, 2026 Jun 16, 2026
8-K Current report
Officer or director change
 Jun 1, 2026 May 27, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Officer or director change
 Apr 20, 2026 Apr 14, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
EFFECT Filing Jan 30, 2026 —
S-1/A Amended registration statement Jan 28, 2026 —
S-1/A Amended registration statement Jan 16, 2026 —
S-1/A Amended registration statement Dec 12, 2025 —
S-1/A Amended registration statement Oct 3, 2025 —
S-1/A Amended registration statement Aug 13, 2025 —
S-1 Registration statement Feb 14, 2025 —

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RVRC (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1839140

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.